SCHEMBL1370873

SCHEMBL1370873

Cc1cccc(-c2ccc(Nc3ccc(N(c4ccccc4)c4ccc(-c5ccc(N(c6ccccc6)c6ccc(Nc7ccc(-c8cccc(C)c8)cc7)cc6)cc5)cc4)cc3)cc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.51
HSD17B1 P14061 1/20 0.48
HSD17B2 P37059 1/20 0.48
HPGD P15428 2/20 0.43
FNTA P49354 1/20 0.43
FNTB P49356 1/20 0.43
MEN1 O00255 1/20 0.40
GAA P10253 1/20 0.40
KMT2A Q03164 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
CTDSP1 Q9GZU7 1/20 0.40
THRB P10828 1/20 0.40
PKM P14618 1/20 0.40
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
RORC P51449 1/20 0.39
MAPK14 Q16539 1/20 0.39
NPC1 O15118 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20945430 0.95 HSD17B1 (0.48) NPSR1HSD17B1HSD17B2HPGDFNTA
SCHEMBL12955702 0.92 NPSR1 (0.64) NPSR1HSD17B1HSD17B2HPGDMEN1
SCHEMBL29359258 0.92 NPSR1 (0.53) NPSR1HSD17B1HSD17B2HPGDMEN1
SCHEMBL3627715 0.91 NPSR1 (0.56) NPSR1HSD17B1HSD17B2HPGDMEN1
SCHEMBL1109738 0.91 NPSR1 (0.56) NPSR1HSD17B1HSD17B2HPGDMEN1
SCHEMBL3461983 0.91 NPSR1 (0.66) NPSR1HPGDMEN1GAAKMT2A
SCHEMBL13175100 0.91 NPSR1 (0.66) NPSR1HPGDMEN1KMT2APOLB
SCHEMBL19185738 0.90 HSD17B1 (0.51) HSD17B1HSD17B2HPGDFNTAFNTB
SCHEMBL10330361 0.90 HSD17B1 (0.51) HSD17B1HSD17B2HPGDFNTAFNTB
SCHEMBL12955676 0.90 NPSR1 (0.60) NPSR1HSD17B1HSD17B2HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110284835-A1 Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110284835-A1 Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same CRY1, CYP1A1, NQO1 NPSR1 2316/4885HSD17B1 2053/4885HSD17B2 1998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.